| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | — | -90.0% |
| R&D Expense | $81.5M | — | -15.6% |
| SG&A Expense | $18.6M | — | -16.5% |
| Operating Income | -$98.4M | — | +3.1% |
| Net Income | -$93.1M | — | +6.0% |
| EPS (Basic) | -$0.74 | — | +59.3% |
| EPS (Diluted) | -$0.74 | — | +59.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $63.9M | -28.8% | -50.3% |
| Current Assets | $532.4M | +67.3% | +136.1% |
| Total Assets | $671.6M | +63.0% | +157.0% |
| Current Liabilities | $70.9M | -3.3% | +17.3% |
| Total Liabilities | $104.6M | -5.5% | +12.5% |
| Stockholders' Equity | $567.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$87.1M | — | -8.4% |
| Capital Expenditures | $164K | — | +343.2% |
| Investing Cash Flow | -$285.7M | — | -824.6% |
| Financing Cash Flow | $347.0M | — | — |
| Free Cash Flow | -$87.2M | — | -8.5% |
| +236.9% |